Kidney Tumor
14
4
4
6
Key Insights
Highlights
Success Rate
86% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
7.1%
1 terminated out of 14 trials
85.7%
-0.8% vs benchmark
0%
0 trials in Phase 3/4
17%
1 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (14)
Virtual Interactive 3D Modelling to Improve Outcomes in Robotic-Assisted Partial Nephrectomy
A Phase II Clinical Two-Stage Study of Transcranial Magnetic Stimulation in Preventing Postoperative Delirium in Elderly Patients After Urological Surgery
Engineering Immune Organoids to Study Pediatric Cancer
Decision Aid (DA) for Renal Patients
CRISPR-Edited HLA Donor Kidney Transplant to Reduce Rejection Risk
Renal Mass Biopsy, PEER, and 99mTc-sestamibi SPECT/CT for Patients With Clinically Localized Renal Tumors
GRADE-SRM: Genomic Risk Assessment and Decisional Evaluation for Small Renal Masses
Liposomal Doxorubicin in Treating Children With Refractory Solid Tumors
Mixed Reality Technology in Laparoscopic Partial Nephrectomy
A Study of Robatumumab (SCH 717454, MK-7454) in Combination With Different Treatment Regimens in Pediatric Participants With Advanced Solid Tumors (P05883, MK-7454-006)
Sildenafil Citrate Before Surgery in Improving Kidney Function in Patients With Kidney Cancer
Ultrasound Elastography in Diagnosing Patients With Kidney or Liver Solid Focal Lesions
IReversible Electroporation of Kidney Tumors Before Partial Nephrectomy.
Imaging During Surgery in Diagnosing Patients With Prostate, Bladder, or Kidney Cancer